proLékaře.cz Journals Contact us Česky
Current issue About the journal Archive Editorial Board Subscription For authors and reviewers Contact us
 
Login |
 
registration
   
have you forgotten your password?
 
send
 

Dyslipidemia in 2012

Authors: M. Vrablík
Authors - sphere of activity: Centrum preventivní kardiologie, III. Interní klinika VFN a 1. LF UK v Praze
Article: Kardiol Rev 2012, 14(1): 37-39
Number of articles displayed: 448x

print print
 
previous article  
zobrazit obsah  show contents  
 
next article
 

Summary

Dyslipidemia in 2012. Therapy of dyslipidemia is a corner stone of prevention of cardiovascular complications in high-risk patients. Best documented lipid lowering agents are statins being used as a mono­therapy as well as the core of combination treatment regimens. Fibrates, ezetimibe, niacin and (in the Czech Republic practically unavailable) resins represent other treatment options of dyslipidemia. Complex intervention of all lipid abnormalities using combination of different drug classes represents an option to accomplish further reduction of cardiovascular atherothrombotic complications.

Keywords:
statins – fibrates – ezetimibe – niacin – cardiovascular risk – atherosclerosis

 
 

Notice

The full wording of this article is available only to registered users. Plese register and you can read this article immediately.

 
 
 

If you are a subscriber, log in and enter the subscriber code from your magazine cover.

If you are not a subscriber, log in for unlimited access to older editions.


Login
Registration

 
 

Odemknout článek:

Nejsem předplatitel

Tento článek si můžete přečíst pokud si aktivujete Premium účet.

 

Journal selection

Display all journals
 
 
reklama
 

Most read